triiodothyronine has been researched along with sirolimus in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fryer, LG; Holness, MJ; Sugden, MC | 1 |
Anderson, NG; Houslay, MD; Kilgour, E; Sale, EM; Sale, GJ; Yarwood, SJ | 1 |
Cao, X; Kambe, F; Moeller, LC; Refetoff, S; Seo, H | 1 |
Kenessey, A; Ojamaa, K | 1 |
Chatterjee, K; Diéguez, C; Gallego, R; Gándara, M; López, M; Martínez-Sánchez, N; Nogueiras, R; Roa, J; Schoenmakers, E; Tena-Sempere, M; Varela, L; Vázquez, MJ | 1 |
Bai, CB; Benson, E; Dutta, R; Edberg, D; Kidd, G; Macklin, WB; Medicetty, S; Roholt, A; Sun, S; Trapp, B | 1 |
Dai, J; Hong, Y; Hu, Y; Jiang, P; Li, R; Liu, D; Lv, H; Song, M; Wang, H; Wang, Z; Yao, S; Zhang, X; Zhao, G; Zhou, Z | 1 |
Dubinski, I; Häberle, B; Küppers, J; Lurz, E; Schmid, I; Schmidt, H; Walther, A | 1 |
Chen, X; Hu, Y; Li, G; Lv, Q; Ren, B; Xie, S; Yang, B; Zhong, R; Zhou, J; Zhu, Y | 1 |
1 review(s) available for triiodothyronine and sirolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for triiodothyronine and sirolimus
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Selective modification of insulin action in adipose tissue by hyperthyroidism.
Topics: Adipose Tissue; Androstadienes; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Nonesterified; Female; Flavonoids; Glucose; Hyperthyroidism; Insulin; Insulin Antagonists; Lipid Metabolism; Lipolysis; Norepinephrine; Polyenes; Rats; Rats, Wistar; Sirolimus; Triiodothyronine; Wortmannin | 1997 |
Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling.
Topics: 3T3 Cells; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; DNA-Binding Proteins; Enzyme Activation; Epidermal Growth Factor; Flavonoids; Growth Hormone; Insulin; Janus Kinase 2; Mice; Milk Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oligonucleotides, Antisense; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Ribosomal Protein S6 Kinases; Signal Transduction; Sirolimus; STAT5 Transcription Factor; Trans-Activators; Transcriptional Activation; Triiodothyronine | 1999 |
Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
Topics: Active Transport, Cell Nucleus; Cells, Cultured; Cycloheximide; Enzyme Activation; Fibroblasts; Gene Expression Regulation; Humans; Ligands; Muscle Proteins; Phosphatidylinositol 3-Kinases; Phosphoserine; Protein Binding; Protein Kinases; Protein Serine-Threonine Kinases; Protein Subunits; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Thyroid Hormone Receptors beta; Time Factors; TOR Serine-Threonine Kinases; Triiodothyronine | 2005 |
Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways.
Topics: Animals; Cells, Cultured; Chromones; Cytosol; Enzyme Activation; Enzyme Inhibitors; Morpholines; Myocytes, Cardiac; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; TOR Serine-Threonine Kinases; Triiodothyronine | 2006 |
Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism.
Topics: Agouti-Related Protein; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Eating; Feeding Behavior; Hyperphagia; Hyperthyroidism; Hypothalamus; Male; Neural Pathways; Neuropeptide Y; Phosphorylation; Pro-Opiomelanocortin; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Sirolimus; Thyroid Hormone Receptors alpha; Time Factors; TOR Serine-Threonine Kinases; Triiodothyronine; Weight Loss | 2012 |
A mouse model for testing remyelinating therapies.
Topics: Animals; Axons; Brain; Calcium-Binding Proteins; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Gliosis; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Monoamine Oxidase Inhibitors; Myelin Proteolipid Protein; Regeneration; Sirolimus; Time Factors; Triiodothyronine; White Matter | 2016 |
Defective autophagy contributes to endometrial epithelial-mesenchymal transition in intrauterine adhesions.
Topics: Actins; Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Cadherins; Cathepsin D; Chloroquine; Endometrium; Epithelial-Mesenchymal Transition; Female; Fibronectins; Fibrosis; Iodide Peroxidase; Lipopolysaccharides; Lysosomal-Associated Membrane Protein 1; Mice; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Phosphates; Proto-Oncogene Proteins c-akt; Sequestosome-1 Protein; Serine; Sirolimus; TOR Serine-Threonine Kinases; Transforming Growth Factor beta; Triiodothyronine | 2022 |
Severe consumptive hypothyroidism in hepatic hemangioendothelioma.
Topics: Hemangioendothelioma; Humans; Hypothyroidism; Infant; Liver Neoplasms; Male; Propranolol; Sirolimus; Thyroid Hormones; Thyroxine; Triiodothyronine | 2022 |
Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells.
Topics: Animals; Endometrial Neoplasms; Eukaryotic Initiation Factor-4G; Female; Humans; Mammals; Progestins; Proto-Oncogene Proteins c-akt; Sirolimus; Thyroid Hormone Receptors beta; TOR Serine-Threonine Kinases; Triiodothyronine | 2022 |